Solid Biosciences Stock Jumps 11% Post-market on FDA Update

Seeking AlphaJan 7 17:23 ET

RBC Capital Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Cuts Target Price to $58

Moomoo NewsJan 7 09:31 ET · Ratings

PTC Therapeutics Price Target Lowered to $58 From $63 at RBC Capital

TipRanksJan 7 08:41 ET

RBC Cuts Price Target on PTC Therapeutics to $58 From $63, Keeps Outperform Rating

MT NewswiresJan 7 07:19 ET · Ratings

Insider Sale: CHIEF EXECUTIVE OFFICER of $PTCT (PTCT) Sells 8,279 Shares

Quiver QuantitativeJan 3 17:34 ET

Insiders At PTC Therapeutics Sold US$1.2m In Stock, Alluding To Potential Weakness

Simply Wall StJan 2 13:36 ET